|
Alprazolam Oral Suspension
» Alprazolam Oral Suspension contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of alprazolam (C17H13ClN4). Prepare Alprazolam Oral Suspension 1 mg per mL as follows (see Pharmaceutical CompoundingNonsterile Preparations
Comminute Tablets in a suitable mortar to a fine powder, or add Alprazolam powder. Add about 20 mL of the Vehicle, and mix until a uniform paste is formed. Add the Vehicle in small portions almost to volume, and mix thoroughly after each addition. Transfer the contents of the mortar, stepwise and quantitatively, to a calibrated bottle. Add sufficient Vehicle to bring to final volume, and mix well.
Packaging and storage
Preserve in tight, light-resistant containers. Store at controlled room temperature, or under refrigeration.
Labeling
Label it to state that it is to be well shaken before use, and to state the beyond-use date.
pH
Beyond-use date:
60 days after the day on which it was compounded.
Assay
Buffer solution
Prepare a 0.04 M sodium acetate solution, and adjust with glacial acetic acid to a pH of 2.4.
Mobile phase
Prepare a filtered and degassed solution of Buffer solution, methanol, and acetonitrile (47:45:8). Make adjustments if necessary (see System Suitability under Chromatography
Standard preparation
Dissolve an accurately weighed quantity of USP Alprazolam RS in Mobile phase, and quantitatively dilute with Mobile phase to obtain a solution having a known concentration of about 20 µg per mL.
Assay preparation
Agitate the container of Alprazolam Oral Suspension for 30 minutes on a rotating mixer, remove a 5-mL sample, and store in a clear glass vial at 70
Chromatographic system (see Chromatography
Procedure
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of alprazolam (C17H13ClN4) in each mL of Oral Suspension taken by the formula:
50(C/V)(rU / rS)
in which C is the concentration, in µg per mL, of USP Alprazolam RS in the Standard preparation; V is the volume, in mL, of Oral Suspension taken; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 1455
Pharmacopeial Forum: Volume No. 32(1) Page 46
|